585 related articles for article (PubMed ID: 11122350)
1. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
2. Role of withdrawal in reinstatement of morphine-conditioned place preference.
Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
Lu L; Liu D; Ceng X
Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats.
Lu L; Ceng X; Huang M
Neuroreport; 2000 Aug; 11(11):2373-8. PubMed ID: 10943688
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes.
Lu L; Liu Z; Huang M; Zhang Z
J Neurochem; 2003 Mar; 84(6):1378-86. PubMed ID: 12614338
[TBL] [Abstract][Full Text] [Related]
6. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal.
Navarro-Zaragoza J; Núñez C; Laorden ML; Milanés MV
Mol Pharmacol; 2010 May; 77(5):864-73. PubMed ID: 20159948
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats.
Ohmura Y; Yamaguchi T; Futami Y; Togashi H; Izumi T; Matsumoto M; Yoshida T; Yoshioka M
Behav Brain Res; 2009 Mar; 198(2):429-33. PubMed ID: 19084036
[TBL] [Abstract][Full Text] [Related]
9. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal.
Iredale PA; Alvaro JD; Lee Y; Terwilliger R; Chen YL; Duman RS
J Neurochem; 2000 Jan; 74(1):199-208. PubMed ID: 10617121
[TBL] [Abstract][Full Text] [Related]
10. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats.
Wang J; Fang Q; Liu Z; Lu L
Psychopharmacology (Berl); 2006 Mar; 185(1):19-28. PubMed ID: 16374599
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of acute morphine, and chronic morphine-withdrawal on obsessive-compulsive behavior: inhibitory influence of CRF receptor antagonists on chronic morphine-withdrawal.
Umathe SN; Mundhada YR; Bhutada PS
Neuropeptides; 2012 Oct; 46(5):217-21. PubMed ID: 22863536
[TBL] [Abstract][Full Text] [Related]
13. The corticotropin-releasing factor receptor-2 mediates the motivational effect of opiate withdrawal.
Rouibi K; Contarino A
Neuropharmacology; 2013 Oct; 73():41-7. PubMed ID: 23707482
[TBL] [Abstract][Full Text] [Related]
14. ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats.
Brugger S; Sánchez R; Brugger AJ; Martinez JA
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):775-85. PubMed ID: 9723119
[TBL] [Abstract][Full Text] [Related]
15. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
Navarro-Zaragoza J; Martínez-Laorden E; Mora L; Hidalgo J; Milanés MV; Laorden ML
Toxicol Appl Pharmacol; 2014 Feb; 275(1):28-35. PubMed ID: 24398105
[TBL] [Abstract][Full Text] [Related]
16. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.
Million M; Maillot C; Saunders P; Rivier J; Vale W; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G34-40. PubMed ID: 11751155
[TBL] [Abstract][Full Text] [Related]
17. Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc).
Almela P; Navarro-Zaragoza J; García-Carmona JA; Mora L; Hidalgo J; Milanés MV; Laorden ML
PLoS One; 2012; 7(10):e47089. PubMed ID: 23071721
[TBL] [Abstract][Full Text] [Related]
18. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
19. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
